Indoco Remedies receives USFDA EIR for Patalganga API facility
USFDA inspection confirms compliance at Indoco Remedies’ Active Pharmaceutical Ingredients manufacturing site
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Indoco Remedies
Indoco’s API manufacturing facility at Patalganga completes US FDA inspection
Indoco Remedies Limited announced today that the United States Food and Drug Administration (USFDA) successfully completed…
Panel Discussion: Aligning packaging strategies with R&D
At the recently held PPL Conclave 2025 in Hyderabad, a panel discussion titled "Aligning Packaging Strategies with R&D"…
Indoco Remedies gains final ANDA approval for Rivaroxaban Tablets USP, 2.5 mg, 10 mg, 15 mg and 20…
Rivaroxaban Tablets USP will be manufactured at the company’s facility located in Goa
Indoco’s Goa Plant II gets EU GMP Compliance-certified
The facility, located in Verna Industrial Estate, manufactures sterile drug products
Panel Discussion: From factory to patient – Just-in-time deliveries
The first panel discussion of the day, titled 'From factory to patient: Just-in-time deliveries,' brought together a powerhouse of…
Indoco launches Ticagrelor film-coated tablets 90mg in the UK market
Indoco Remedies UK begins distribution of cardiovascular treatment via Clarity Pharma across the United Kingdom
Indoco Remedies gains USFDA final approval for Allopurinol Tablets USP 200 mg
Allopurinol prevents or lowers high uric acid levels caused by cancer medicines or in patients with kidney stones
Indoco strategic collaboration aims to strengthen Indoco Remedies’ presence in the UK pharma market
Remedies partners with Clarity Pharma to launch 20 products in the UK
Uhlmann India inaugurates new office and showcases blister packaging solutions
Uhlmann India marks the inauguration of its new office and hosts an in-house event with industry leaders, partners, and customers,…